Tag: Barostim
CVRx announces initiation of BENEFIT-HF trial of Barostim device in “significantly expanded population”
CVRx recently announced the start of the BENEFIT-HF clinical trial, a randomised study designed ...
CVRx launches new version of neuromodulation device intended to treat heart failure
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodula...
US physicians “among nation’s first” to implant neurostimulator technology for advanced heart failure
Doctors at St David's Medical Center in Austin, USA recently implanted a new neurostimulator technol...
